MedPath

Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women

Completed
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
Behavioral: Education
Registration Number
NCT01272726
Lead Sponsor
Avera McKennan Hospital & University Health Center
Brief Summary

The goal of this research study is to measure what percentage of women who suspect they have symptoms of ADHD will go on to be diagnosed with ADHD using accepted practice standards. The study will also evaluate the influence education on the genetics of ADHD has on a woman in her deciding to receive behavioral health treatment for ADHD.

Detailed Description

Attention Deficit Hyperactivity Disorder (ADHD) affects approximately 10-12% of school-aged children in the United States, making it one of the most common psychiatric disorders in children. It is characterized as inattention and hyperactivity-impulsivity, which has persisted for at least 6 months to a degree that is maladaptive and inconsistent with developmental level (DSM-IV-TR). ADHD is a non-fluctuating illness unlike many other psychiatric co-morbid conditions.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Subjects must be females, 18 through 59 years of age
  • Subjects must think they have ADHD or have been previously diagnosed with ADHD but may not have received any treatment for ADHD
  • Subjects must be able to participate in the informed consent process and give their written consent to participate in the study
Exclusion Criteria
  • Subjects who have been treated (at any time) for ADHD will be excluded from the study
  • Potential subjects consuming greater than 21 units of alcohol (1 unit=12.0 ounces beer, 1.5 ounces hard liquor or 5.0 ounces wine) a week will be excluded from the study
  • Potential subjects currently experiencing suicidal ideation or who have been hospitalized within the past six months for suicidal ideation will be excluded from the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ADHDEducationWomen with symptoms of ADHD. Women who either think they may have ADHD or have been previously diagnosed with ADHD but have not been treated for it.
Primary Outcome Measures
NameTimeMethod
To determine if offering relative risk genotyping for ADHD, and educating around the genetic and environmental contributions to ADHD, may lead to greater health care acceptance in women who struggle with ADHD.24 hours
Secondary Outcome Measures
NameTimeMethod
To determine if women who think they have ADHD actually have ADHD.24 hours

Trial Locations

Locations (1)

Avera Research Institute

🇺🇸

Sioux Falls, South Dakota, United States

© Copyright 2025. All Rights Reserved by MedPath